It is a chemicals private limited company based in Jaipur, Rajasthan, India, established in 2020.
2020 | Jaipur, Rajasthan, India | ActiveSuryaanjan Pharmaceuticals India Private Limited, a active private limited company, was established on 19 July 2020 in Jaipur, Rajasthan, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24231RJ2020PTC069704. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Its leadership includes Ravi Kumar Soni (Director), Anjana Soni (Director). Past directors included Dipesh Joshi. It holds ₹2.04 M open charges and ₹1.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 62B, Prem Nagar,Gurjar Ki Thadi, Jaipur, Rajasthan, 302019.
U24231RJ2020PTC069704
069704
19 July 2020
₹1.50 M
₹1.50 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Suryaanjan Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Kumar Soni | Director | 19 Jul 2020 | Current |
| Anjana Soni | Director | 19 Jul 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Oct 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Suryaanjan Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1861.92% increase. The company also saw a substantial improvement in profitability, with a 121.62% increase in profit. The company's net worth moved up by a moderate rise of 3.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Suryaanjan Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,040,000.00
₹1,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Aug 2025 | Idbi Bank Limited | ₹2.04 M | Open |
| 17 Oct 2020 | Idbi Bank Limited | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Suryaanjan Pharmaceuticals India has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Suryaanjan Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suryaanjan Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 17 Oct 2020 via Charge ID 100466080 with Idbi Bank Limited was fully satisfied on 17 Sep 2025. was recorded as a recent event.
Progress on A charge with Idbi Bank Limited amounted to Rs. 2.04 M with Charge ID 101137833 was registered on 02 Aug 2025. was documented.
The activity Suryaanjan Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Suryaanjan Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was documented.
Progress on A charge with Idbi Bank Limited amounted to Rs. 1.00 M with Charge ID 100466080 was registered on 17 Oct 2020. was documented.
Progress on Ravi Kumar Soni was appointed as a Director was appointed as a Director on 19 Jul 2020 & has been associated with this company since 5 years 4 months . was documented.
The CIN of Suryaanjan Pharmaceuticals India Private Limited is U24231RJ2020PTC069704.
Suryaanjan Pharmaceuticals India Private Limited is headquartered at 62B, Prem Nagar,Gurjar Ki Thadi, Jaipur, Rajasthan, 302019.
Suryaanjan Pharmaceuticals India Private Limited was incorporated on 19 July 2020.
The current directors of Suryaanjan Pharmaceuticals India Private Limited are
The primary industry of Suryaanjan Pharmaceuticals India Private Limited is Chemicals.
Suryaanjan Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Suryaanjan Pharmaceuticals India Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX